Davis Todd C 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Davis Todd C（CIK 1392029）在 2 家公司共报告 20 笔 SEC Form 4 内部人交易（最近一笔 2026-07-06）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 132 | $21,214 |
| 2026-06-15 | Pelthos Therapeutics Inc. (PTHS) | 董事 | 买入 | 35,445 | $985,371 |
| 2026-06-15 | Pelthos Therapeutics Inc. (PTHS) | 董事 | 买入 | 503 | $14,451 |
| 2026-04-01 | Pelthos Therapeutics Inc. (PTHS) | 董事 | 买入 | 12,900 | $0 |
| 2026-04-01 | Pelthos Therapeutics Inc. (PTHS) | 董事 | 买入 | 4,961 | $0 |
| 2026-04-01 | Pelthos Therapeutics Inc. (PTHS) | 董事 | 买入 | 19,108 | $0 |
| 2026-03-27 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 10,495 | $0 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 20,782 | $0 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 卖出 | 8,178 | $1.5M |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 39,644 | $0 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 卖出 | 15,600 | $2.9M |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 卖出 | 2,039 | $374,829 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 卖出 | 4,255 | $782,197 |
| 2026-02-18 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 卖出 | 2,805 | $515,643 |
| 2025-12-08 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 卖出 | 130 | $0 |
| 2025-07-03 | Pelthos Therapeutics Inc. (PTHS) | 董事 | 买入 | 1.5M | $15.0M |
| 2025-07-02 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 233 | $21,222 |
| 2025-05-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 1,680 | $175,678 |
| 2025-05-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 2,307 | $241,151 |
| 2025-05-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Executive Officer | 买入 | 5,523 | $583,615 |
来源：SEC Form 4 申报文件 · 截至 2026-07-06